ScienceDex / Researcher record
Gary Fanger
- Rise Therapeutics, Llc (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
- Diverse Portfolio
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $5,683,067 | 7 | #918 |
| 2025 | $2,914,403 | 4 | #3,582 |
| 2026 | $3,069,050 | 4 | #5,956 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20247 records
- FY20254 records
- FY2026 · selected4 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14958505Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award records by amount
NIH award records listing Gary Fanger as a PI. Multi-PI records show the full award amount for context.
- 5R44AG084484-04R44Contact PIA Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis$967.7Kaward amount
- 5SB1DK141356-03SB1Contact PIA Novel Synthetically Engineered Oral Immunotherapy for Treating Ulcerative Colitis$811.4Kaward amount
- 1R44CA306440-01A1R44Contact PIClinical Validation of a Synthetic Biology-Based Microbial Medicine to Treat Immunotherapy Refractory Solid Tumors$740.1Kaward amount
- 4UH3DE034134-02UH3Contact PIA Novel Immunological-Directed Probiotic for the Treatment of Sjögren’s Syndrome$549.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Gary Fanger as a PI.
FY2026 award administered by Rise Therapeutics, Llc (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardRise Therapeutics, Llc
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #918
- 2024Entered Top 25% NationallyRanked #918
- 2024Entered Top 10% NationallyRanked #918
- 2024Entered Top 5% NationallyRanked #918
- 2026$10M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Gary Fanger.